Role of the glucose-dependent insulinotropic polypeptide and its receptor in the central nervous system: therapeutic potential in neurological diseases.
about
Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitusTranscriptional analysis of apoptotic cerebellar granule neurons following rescue by gastric inhibitory polypeptideTemporal and Regional Expression of Glucose-Dependent Insulinotropic Peptide and Its Receptor in Spinal Cord Injured Rats.The DPP-4 inhibitor linagliptin counteracts stroke in the normal and diabetic mouse brain: a comparison with glimepirideNeuroprotective effects of D-Ala(2)GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model.Glucose-Dependent Insulinotropic Polypeptide Ameliorates Mild Traumatic Brain Injury-Induced Cognitive and Sensorimotor Deficits and Neuroinflammation in Rats.Update on incretin hormones.Antidiabetic treatment, stroke severity and outcomeNeuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease.Central GIP signaling stimulates peripheral GIP release and promotes insulin and pancreatic polypeptide secretion in nonhuman primates.Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.Intestinal Incretins and the Regulation of Bone Physiology.Glucose-dependent insulinotropic polypeptide receptor knockout mice are impaired in learning, synaptic plasticity, and neurogenesis.Evaluation of the long-term effects of gastric inhibitory polypeptide-ovalbumin conjugates on insulin resistance, metabolic dysfunction, energy balance and cognition in high-fat-fed mice.Glucose-Dependent Insulinotropic Polypeptide Mitigates 6-OHDA-Induced Behavioral Impairments in Parkinsonian Rats.
P2860
Q26774021-5C90657A-C2D2-46DF-B551-0E1CECC070B0Q33580451-D853F65E-F108-466F-9CB3-38E43DAC09A3Q36554957-4D93BCD2-36BD-4847-B318-458AAE97CA8FQ36720655-1D5CF354-375F-4C8B-8B12-D117E6D86D9EQ36997912-16DB392B-FA5D-4752-A0AC-6765BA52822EQ37424923-058E3FA4-EB59-4D32-B14C-E98F1E29CB12Q38006504-676461D4-5049-4FF7-B7DD-A4956807FC8DQ38205762-B715D34E-5BA7-41FC-85CA-F31C9F013AB9Q38583347-7D672283-EF9F-4261-918D-B850189A0EBFQ39485182-0A1D7435-EAC3-44FA-916B-FD839C9EA223Q39570654-7C9947E2-B190-4A97-8BDE-A79B57D4CBC3Q49015193-29565A92-FD6B-4E86-ADF3-579AD3277B7FQ50171023-CC89DBF0-8CD8-49E1-AEE3-9150CD96CBC7Q51021916-43CE5673-E926-498F-8094-C0D821F918CEQ51362307-34017B9B-E2CC-4A28-A6F6-83860FD720B7Q52594233-38ECD48E-3F3E-4EC2-8072-9BD58A4B8C1E
P2860
Role of the glucose-dependent insulinotropic polypeptide and its receptor in the central nervous system: therapeutic potential in neurological diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of the glucose-dependent ...... tial in neurological diseases.
@en
Role of the glucose-dependent ...... tial in neurological diseases.
@nl
type
label
Role of the glucose-dependent ...... tial in neurological diseases.
@en
Role of the glucose-dependent ...... tial in neurological diseases.
@nl
prefLabel
Role of the glucose-dependent ...... tial in neurological diseases.
@en
Role of the glucose-dependent ...... tial in neurological diseases.
@nl
P50
P1476
Role of the glucose-dependent ...... ntial in neurological diseases
@en
P2093
Aderbal S Aguiar
Tânia L Mazzuco
P304
P356
10.1097/FBP.0B013E32833C8544
P577
2010-09-01T00:00:00Z